精准医疗软体市场规模、份额和成长分析（按交付方式、按应用、按最终用户、按地区）：产业预测 (2024-2031)

2022年全球精准医疗软体市场规模为13.1亿美元，从2023年的14.8亿美元成长到2031年的38.1亿美元，预测期间（2024-2031年）预计复合年增长率为12.6%。

在技​​术进步和对个人化医疗解决方案日益增长的需求的推动下，全球精准医疗软体市场正在迅速发展。该软体使医疗保健提供者能够分析大量患者资料并製定考虑遗传、环境和生活方式变化的客製化治疗计划。市场扩张的主要驱动因素包括慢性病盛行率的上升、基因组学和蛋白​​质组学的进步、电子健康记录的日益普及以及政府的支持政策。此外，人工智慧和机器学习演算法的结合增强了精准医疗软体的功能，并有望在不久的将来进一步推动市场成长。整体趋势强调转向客製化医疗方法，以优化患者的治疗结果。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

全球精准医疗软体市场规模及复合年增长率：以交付方式划分（2024-2031）

• 市场概况
• 云端基础
• 本地

全球精准医疗软体市场规模及复合年增长率：依应用分类（2024-2031）

• 市场概况
• 肿瘤学
• 药物基因体学
• 罕见疾病

全球精准医疗软体市场规模与复合年增长率：依最终用户划分（2024-2031）

• 市场概况
• 医疗提供者
• 研究中心/学术机构
• 製药和生物技术公司

全球精准医疗软体市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• IBM Watson Health
• Oracle Corporation
• SAP SE
• SAS Institute Inc.
• Microsoft Corporation
• Flatiron Health, Inc.
• Syapse, Inc.
• Fabric Genomics, Inc.
• N-of-One, Inc.
• Gene42, Inc.
• PierianDx
• LifeOmic
• Tempus Labs, Inc.
• 2bPrecise LLC
• Human Longevity, Inc.
• GNS Healthcare
• Seven Bridges Genomics
• WuXi NextCODE
• Foundation Medicine, Inc.
• Strand Life Sciences

结论和建议

Global Precision Medicine Software Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.81 billion by 2031, growing at a CAGR of 12.6% during the forecast period (2024-2031).

The global precision medicine software market is rapidly evolving, fueled by technological advancements and a growing demand for personalized healthcare solutions. This software empowers healthcare providers to analyze extensive patient data, enabling customized treatment plans that account for genetic, environmental, and lifestyle variations. Key drivers of market expansion include the rising incidence of chronic diseases, advancements in genomics and proteomics, a growing adoption of electronic health records, and supportive government policies. Additionally, the incorporation of artificial intelligence and machine learning algorithms is poised to enhance the capabilities of precision medicine software, further propelling market growth in the near future. The overall trend underscores a transformative shift towards tailored healthcare approaches, optimizing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Medicine Software Market Segmental Analysis

Global Precision Medicine Software Market is segmented by delivery mode, application, end user and region. Based on delivery mode, the market is segmented into web & cloud-based and on-premises. Based on application, the market is segmented into oncology, pharmacogenomics and rare diseases. Based on end user, the market is segmented into healthcare providers, research centers and academic institutes and pharmaceutical and biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Medicine Software Market

A significant driver of the global precision medicine software market is the rising demand for personalized healthcare solutions. As precision medicine focuses on delivering customized treatments tailored to an individual's unique genetic profile, lifestyle, and environmental influences, the need for corresponding software has surged. Technological advancements in genomic sequencing and big data analytics have made it easier to incorporate precision medicine into healthcare practices. This software allows providers to sift through extensive patient data, including genetic and medical histories, along with real-time monitoring, enabling more personalized treatment decisions. Growing awareness among patients and healthcare professionals about precision medicine's benefits continues to amplify the demand for supporting software solutions.

Restraints in the Global Precision Medicine Software Market

The global precision medicine software market faces significant restraints primarily due to the complexity and high costs involved in implementation and integration. This field necessitates the handling of vast amounts of genomic and clinical data, which requires sophisticated software systems capable of accurate analysis. However, healthcare organizations often encounter challenges, including interoperability issues and data privacy concerns, which complicate the integration process. Moreover, the extensive training required for healthcare professionals adds another layer of difficulty. High acquisition, maintenance, and upgrading costs further deter smaller healthcare institutions or those in resource-limited areas, hindering their capacity to adopt these advanced medical technologies.

Market Trends of the Global Precision Medicine Software Market

The global precision medicine software market is currently experiencing transformative trends that are reshaping healthcare delivery. A notable trend is the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies, which enhance diagnostic accuracy and facilitate the development of tailored treatment plans, ultimately leading to improved patient outcomes. Additionally, the increased embrace of cloud-based platforms is driving the secure, efficient storage and analysis of vast genomic and clinical datasets, further streamlining workflows. Moreover, a strong emphasis on interoperability and data standardization is fostering better integration among disparate healthcare systems, promoting collaboration among providers. Collectively, these trends are accelerating the adoption of precision medicine software, positioning it as a cornerstone of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Precision Medicine Software Market Size by Delivery Mode & CAGR (2024-2031)

• Market Overview
• Web & Cloud-Based
• On-Premises

Global Precision Medicine Software Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Pharmacogenomics
• Rare Diseases

Global Precision Medicine Software Market Size by End User & CAGR (2024-2031)

• Market Overview
• Healthcare Providers
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies

Global Precision Medicine Software Market Size & CAGR (2024-2031)

• North America (Delivery Mode, Application, End User)
  • US
  • Canada
• Europe (Delivery Mode, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Delivery Mode, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Delivery Mode, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Delivery Mode, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAP SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fabric Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• N-of-One, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene42, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PierianDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeOmic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2bPrecise LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Longevity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNS Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi NextCODE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strand Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation